Literature DB >> 31040229

A post-transplant optimized transplant-specific risk score in myelodysplastic syndromes.

Mahasweta Gooptu1, John Koreth1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31040229      PMCID： PMC6518899          DOI： 10.3324/haematol.2018.214452

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

2.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

3.  Role of reduced-intensity conditioning allogeneic hematopoietic stem-cell transplantation in older patients with de novo myelodysplastic syndromes: an international collaborative decision analysis.

Authors:  John Koreth; Joseph Pidala; Waleska S Perez; H Joachim Deeg; Guillermo Garcia-Manero; Luca Malcovati; Mario Cazzola; Sophie Park; Raphael Itzykson; Lionel Ades; Pierre Fenaux; Martin Jadersten; Eva Hellstrom-Lindberg; Robert Peter Gale; C L Beach; Stephanie J Lee; Mary M Horowitz; Peter L Greenberg; Martin S Tallman; John F DiPersio; Donald Bunjes; Daniel J Weisdorf; Corey Cutler
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

4.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

Authors:  R Coleman Lindsley; Wael Saber; Brenton G Mar; Robert Redd; Tao Wang; Michael D Haagenson; Peter V Grauman; Zhen-Huan Hu; Stephen R Spellman; Stephanie J Lee; Michael R Verneris; Katharine Hsu; Katharina Fleischhauer; Corey Cutler; Joseph H Antin; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

5.  Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Authors:  Francisco M Marty; Per Ljungman; Roy F Chemaly; Johan Maertens; Sanjeet S Dadwal; Rafael F Duarte; Shariq Haider; Andrew J Ullmann; Yuta Katayama; Janice Brown; Kathleen M Mullane; Michael Boeckh; Emily A Blumberg; Hermann Einsele; David R Snydman; Yoshinobu Kanda; Mark J DiNubile; Valerie L Teal; Hong Wan; Yoshihiko Murata; Nicholas A Kartsonis; Randi Y Leavitt; Cyrus Badshah
Journal:  N Engl J Med       Date:  2017-12-06       Impact factor: 91.245

6.  Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Authors:  Matteo G Della Porta; Emilio Paolo Alessandrino; Andrea Bacigalupo; Maria Teresa van Lint; Luca Malcovati; Cristiana Pascutto; Michele Falda; Massimo Bernardi; Francesco Onida; Stefano Guidi; Anna Paola Iori; Raffaella Cerretti; Paola Marenco; Pietro Pioltelli; Emanuele Angelucci; Rosi Oneto; Francesco Ripamonti; Paolo Bernasconi; Alberto Bosi; Mario Cazzola; Alessandro Rambaldi
Journal:  Blood       Date:  2014-02-20       Impact factor: 22.113

7.  Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

Authors:  Brian C Shaffer; Kwang Woo Ahn; Zhen-Huan Hu; Taiga Nishihori; Adriana K Malone; David Valcárcel; Michael R Grunwald; Ulrike Bacher; Betty Hamilton; Mohamed A Kharfan-Dabaja; Ayman Saad; Corey Cutler; Erica Warlick; Ran Reshef; Baldeep Mona Wirk; Mitchell Sabloff; Omotayo Fasan; Aaron Gerds; David Marks; Richard Olsson; William Allen Wood; Luciano J Costa; Alan M Miller; Jorge Cortes; Andrew Daly; Tamila L Kindwall-Keller; Rammurti Kamble; David A Rizzieri; Jean-Yves Cahn; Robert Peter Gale; Basem William; Mark Litzow; Peter H Wiernik; Jane Liesveld; Bipin N Savani; Ravi Vij; Celalettin Ustun; Edward Copelan; Uday Popat; Matt Kalaycio; Richard Maziarz; Edwin Alyea; Ron Sobecks; Steven Pavletic; Martin Tallman; Wael Saber
Journal:  J Clin Oncol       Date:  2016-04-04       Impact factor: 44.544

8.  A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Authors:  Corey S Cutler; Stephanie J Lee; Peter Greenberg; H Joachim Deeg; Waleska S Pérez; Claudio Anasetti; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; John P Klein; Hillard M Lazarus; Jane L Liesveld; Philip L McCarthy; Gustavo A Milone; J Douglas Rizzo; Kirk R Schultz; Michael E Trigg; Armand Keating; Daniel J Weisdorf; Joseph H Antin; Mary M Horowitz
Journal:  Blood       Date:  2004-03-23       Impact factor: 22.113

9.  Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

Authors:  Matteo G Della Porta; Anna Gallì; Andrea Bacigalupo; Silvia Zibellini; Massimo Bernardi; Ettore Rizzo; Bernardino Allione; Maria Teresa van Lint; Pietro Pioltelli; Paola Marenco; Alberto Bosi; Maria Teresa Voso; Simona Sica; Mariella Cuzzola; Emanuele Angelucci; Marianna Rossi; Marta Ubezio; Alberto Malovini; Ivan Limongelli; Virginia V Ferretti; Orietta Spinelli; Cristina Tresoldi; Sarah Pozzi; Silvia Luchetti; Laura Pezzetti; Silvia Catricalà; Chiara Milanesi; Alberto Riva; Benedetto Bruno; Fabio Ciceri; Francesca Bonifazi; Riccardo Bellazzi; Elli Papaemmanuil; Armando Santoro; Emilio P Alessandrino; Alessandro Rambaldi; Mario Cazzola
Journal:  J Clin Oncol       Date:  2016-10-20       Impact factor: 44.544

10.  Optimized EBMT transplant-specific risk score in myelodysplastic syndromes after allogeneic stem-cell transplantation.

Authors:  Nico Gagelmann; Diderik-Jan Eikema; Matthias Stelljes; Dietrich Beelen; Liesbeth de Wreede; Ghulam Mufti; Nina Simone Knelange; Dietger Niederwieser; Lone S Friis; Gerhard Ehninger; Arnon Nagler; Ibrahim Yakoub-Agha; Ellen Meijer; Per Ljungman; Johan Maertens; Lothar Kanz; Lucia Lopez-Corral; Arne Brecht; Charles Craddock; Jürgen Finke; Jan J Cornelissen; Paolo Bernasconi; Patrice Chevallier; Jorge Sierra; Marie Robin; Nicolaus Kröger
Journal:  Haematologica       Date:  2019-01-17       Impact factor: 9.941
View more
  1 in total

1.  Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome.

Authors:  Silvia Park; Tong Yoon Kim; Jong Hyuk Lee; Joon Yeop Lee; Gi June Min; Sung Soo Park; Seung-Ah Yahng; Seung-Hwan Shin; Jae-Ho Yoon; Sung-Eun Lee; Byung Sik Cho; Ki-Seong Eom; Seok Lee; Hee-Je Kim; Chang-Ki Min; Jong Wook Lee; Yoo-Jin Kim
Journal:  Ther Adv Hematol       Date:  2021-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.